Amsterdam, 15 November 2022 – Teledyne DALSA, a Teledyne Technologies company and global leader in Digital X-Ray Image Sensing technology, is pleased to announce it has acquired the Sigmascreening B.V. patents and IP portfolio on pressure-sensitive breast compression for screening. With its purchase, Teledyne DALSA has exclusive access to the Sigmascreening IP portfolio and algorithms. Holland Capital was one of the early investors in Sigmascreening.

Unique combination

The unique combination of detector and pressure-sensitive compression is expected to create new possibilities for immediate diagnostic information as well as biomarkers for breast screening. According to Thorsten Achterkirchen, Vice President and General Manager of Teledyne DALSA’s X-Ray Solutions business, “We intend to expand our CMOS X-Ray detector product line for mammography and digital breast tomosynthesis (DBT) with new subsystem products for optimizing breast imaging and improving patient comfort during mammographic screening.”

Ivo Aarninkhof, CEO of Sigmascreening, says that ‘’We are delighted with the purchase of the Sigmascreening patents and IP portfolio by Teledyne DALSA. Use of the pressure-based compression during digital breast tomosynthesis and mammography improves participant and technologist experience and reduces compression pressure variability, mean breast thickness, and glandular dose.”1

Expertise in radiology

Holland Capital joined the company in 2014 as an early investor. The investment has been used for product development and commercial growth in recent years. Holland Capital is experienced in supporting innovative radiology solutions. This is the investor’s second exit in the field of medical imaging, following the acquisition of Quantib, a leading radiology artificial intelligence (“AI”) company, by RadNet Inc earlier this year.

Jan-Frens van Giessel, Partner Holland Capital : “We are proud that we have been able to assist Sigmascreening in the past 8 years. Sigmascreening’s pressure sensitive breast compression reduces extreme pain during mammography and improves detection of breast cancer. It is great to see that this important healthcare innovation will become available for women worldwide with the acquisition of Teledyne DALSA.”

About Teledyne DALSA

Teledyne DALSA provides state-of-the-art image sensing, capture and processing solutions to medical, dental, and scientific equipment manufacturers. Building on more than 30 years of proven capability and innovation, our highly skilled team of imaging specialists adds value with their continued focus on leading-edge product design. Our manufacturing processes are tailored to comply with the stringent quality, reliability, and traceability requirements of the medical and scientific X-ray community.

About Sigmascreening

Sigmascreening B.V. is a medical device company focusing on the development of new innovative products in the area of digital mammography and breast cancer screening. Sigmascreening was established as a spin-off company from the Amsterdam UMC.

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team understand entrepreneurship. They aim to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful Healthcare and Technology entrepreneurs.

1 quote is based on this scientific article: https://academic.oup.com/jbi/advance-article/doi/10.1093/jbi/wbaa070/5902745

Holland Capital investeert in Curess

Holland Capital investeert in Curess

Holland Capital participeert in Curess, een vooraanstaande organisatie in de jeugdzorg gericht op systemische gezinsondersteuning. Door middel van de samenwerking met Holland Capital kan verdere groei en ontwikkeling gerealiseerd worden.

Ondernemer wordt investeerder

Ondernemer wordt investeerder

Holland Capital genomineerd voor 4 M&A Awards. Marijn Silvis genomineerd voor Best Young PE Manager. Valori genomineerd voor Best Small Cap Deal. Best Venture & Growth Capital Provider. Best Private Equity House Lower Mid-Market.

Emixa kondigt rebranding van gelieerde bedrijven aan

Emixa kondigt rebranding van gelieerde bedrijven aan

Ons portfoliobedrijf Emixa, de toonaangevende technologiepartner voor SAP/Siemens/Mendix, rondt de laatste fase van zijn rebranding naar één merk af. De meest recente acquisitie, LMtec Digital Solutions krijgt vanaf vandaag de naam Emixa DACH!

Holland Capital investeert in Hybrid Power Units & Top Systems

Holland Capital investeert in Hybrid Power Units & Top Systems

Holland Capital investeert in Hybrid Power Units & Top Systems Amsterdam / Stadskanaal / Bodegraven, 22 april 2024 - Holland Capital investeert in Hybrid Power Units (‘HPU’) en Top Systems (‘TS’), beide bedrijven leveren energie oplossingen op basis van...

De YOEP-groep bundelt krachten met PHHaastrecht

De YOEP-groep bundelt krachten met PHHaastrecht

De YOEP-groep bundelt krachten met PHHaastrecht Amsterdam, 15 april 2024 - Onze deelneming de YOEP-groep gaat samen verder met PHHaastrecht. Door de krachtenbundeling, die door Holland Capital mogelijk wordt gemaakt, versterkt de YOEP-groep haar jeugdzorg en...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01